.. | ||
cca.molgen.TA | ||
cca.molgen.TB | ||
cca.T.clinical_scoring_system | ||
cca.T.disorders_to_consider_in_the_diffe | ||
cca.T.molecular_genetic_testing_used_in | ||
cca.T.notable_fbn2_pathogenic_variants | ||
cca.T.recommended_evaluations_following | ||
cca.T.recommended_evaluations_following_1 | ||
cca.T.recommended_surveillance_for_indiv | ||
cca.T.selected_clinical_features_in_clas | ||
cca.T.treatment_of_manifestations_in_ind | ||
cca.T.treatment_of_manifestations_in_ind_1 |